SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Preliminary Results Demonstrate That the Novel Delivery of Dexamethasone via Mercator MedSystems, Inc.’s Platform Micro-Infusion Catheter Inhibits Restenosis for at Least 9 Months in 10 Patients Treated for Peripheral Vascular Disease (PAD)